Paediatric Drugs

, Volume 3, Issue 6, pp 438–439 | Cite as


A Viewpoint by Dr Stan Goldman
  • Stan Goldman
Adis New Drug Profile Guest Commentary


Uric Acid Allopurinol Uric Acid Level Serum Uric Acid Level Allantoin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bowman WP, Shuster JJ, Cook B, et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol 1996; 14: 1252–61PubMedGoogle Scholar
  2. 2.
    Patte C, Michon J, Bouffet E, et al. High survival rate of childhood B-cell lymphoma and leukemia (ALL) as a result of the LMB 89 protocol of the SFOP (French Pediatric Oncology Society) [abstract]. Proc Am Soc Oncol 1992: 11Google Scholar
  3. 3.
    Pui CH, Relling MV, Lascombes F, et al. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia 1997; 11: 1813–6PubMedCrossRefGoogle Scholar
  4. 4.
    Goldman SC, Holcenberg JS, Finklestein JZ, et al. A randomised comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk of tumor lysis. Blood 2001; 97(10): 2998–3003PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2001

Authors and Affiliations

  • Stan Goldman
    • 1
  1. 1.Pediatric Hematology/OncologyNorth Texas Hospital for Children at Medical City Dallas and Texas Oncology, P.A.DallasUSA

Personalised recommendations